Angiogenesis Inhibitors in Small Cell Lung Cancer

Angiogenesis Inhibitors in Small Cell Lung Cancer

Inhibition of angiogenesis has been demonstrated to be an efficacious strategy in treating several tumors. Vascular endothelial growth factor (VEGF) is the most important protein with proangiogenic functions and it is overexpressed in small cell lung cancer (SCLC). Bevacizumab, a monoclonal antibody...

Full description

Bibliographic Details
Main Authors: Agnese Montanino, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Vincenzo Sforza, Raffaele Costanzo, Claudia Sandomenico, Gerardo Botti, Maria C. Piccirillo, Priscilla Cascetta, Giacomo Pascarella, Carmine La Manna, Nicola Normanno, Alessandro Morabito
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
small cell lung cancer
angiogenesis
vascular endothelial growth factor
bevacizumab
anlotinib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.655316/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.655316/full

Similar Items